Viewing Study NCT05186558


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-25 @ 8:30 PM
Study NCT ID: NCT05186558
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-03-07
First Post: 2021-12-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Large B-Cell, Diffuse View
None Neoplasms by Histologic Type View
Keywords: